About Index Trending news
Analyze
Top 50 Pricing
Genkyotex S.A

Genkyotex S.A

Work at Genkyotex S.A? Add yourself to this profile

Genkyotex S.A

Genkyotex develops innovative drugs to block the NOX enzymes that produce oxygen radicals.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series D)
$21,000,000
VI Partners, Neomed Management, Edmond de Rothschild Venture Capital, +3
Venture capital (Series C)
$26,000,000
MP Healthcare Venture Management, Edmond de Rothschild Venture Capital, Eclosion SA, +1
Employees

Unknown size

Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Genkyotex S.A makes some noise.